Differentiation of iPSCs

The induced pluripotent stem (iPS) cells from patient's somatic cells could be a useful source for drug discovery and cell transplantation therapies. To date, most iPS cells were made by using viral vectors, such as retroviruses and lentiviruses. Here we describe a stepwise protocol for the generation of modified virus-derived iPS cells from primary human fibroblasts. https://www.creative-bioarray.com/support/reprogramming-of-human-fibroblasts-into-ipscs.htm